Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

书目详细资料
Main Authors:	Bafadhel, M, Sing, D, Jenkins, C, Peterson, S, Bengtsson, T, Fageras, M
格式:	Conference item
出版:	European Respiratory Society 2018

相似书籍

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
由: Bafadhel, M, et al.
出版: (2018)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
由: Bafadhel, M, et al.
出版: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
由: Russell, R, et al.
出版: (2018)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
由: Pavord, I, et al.
出版: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
由: Asciak, R, et al.
出版: (2017)

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
由: Bafadhel, M, et al.
出版: (2018)

Blood eosinophil count and exacerbation risk in patients with COPD.
由: Kerkhof, M, et al.
出版: (2017)

Characterising non-eosinophilic COPD
由: Hambleton, K, et al.
出版: (2015)

Eosinophils in COPD: just another biomarker?
由: Bafadhel, M, et al.
出版: (2017)

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
由: Bafadhel M, et al.
出版: (2022-12-01)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
由: Antonella Casiraghi, et al.
出版: (2020-03-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
由: Shrimanker, R, et al.
出版: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
由: Sandra Martínez-Gestoso, et al.
出版: (2021-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
由: Oh YM, et al.
出版: (2018-10-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
由: Lababidi, R, et al.
出版: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
由: Djamin, R, et al.
出版: (2019)

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis
由: Antonio Spennacchio, et al.
出版: (2024-04-01)

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
由: Manzetti GM, et al.
出版: (2023-10-01)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
由: Tomoki Maetani, et al.
出版: (2023-10-01)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
由: Shigeo Muro, et al.
出版: (2021-06-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
由: Hambleton, K, et al.
出版: (2016)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
由: Tzu-Tao Chen, et al.
出版: (2023-12-01)

Current smoking reduces small airway eosinophil counts in COPD
由: Augusta Beech, et al.
出版: (2024-01-01)

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
由: Shigeo Muro, et al.
出版: (2021-08-01)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
由: Hambleton, K, et al.
出版: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
由: Kerkhof, M, et al.
出版: (2017)

Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
由: Saya Nakamura, et al.
出版: (2024-10-01)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
由: Augusta Beech, et al.
出版: (2022-10-01)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
由: Greulich T, et al.
出版: (2018-09-01)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
由: Marjan Kerkhof, et al.
出版: (2020-11-01)

Budesonide/formoterol combination in COPD: a US perspective
由: Amir Sharafkhaneh, et al.
出版: (2010-10-01)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
由: Ramsheh, M, et al.
出版: (2018)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
由: Caroline Michèle Andrist, et al.
出版: (2020-12-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
由: Song JH, et al.
出版: (2017-08-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
由: Bafadhel, M, et al.
出版: (2016)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
由: Russell, R, et al.
出版: (2016)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
由: George, L, et al.
出版: (2019)

Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization
由: Bélanger M, et al.
出版: (2018-10-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
由: Belchamber KBR, et al.
出版: (2018-09-01)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
由: Bafadhel, M, et al.
出版: (2014)